The latest news about psychopharmacology and drug research
New research helps identify some of the differences between the cognitive effects of classical hallucinogens…
Alcohol intoxication can impair the ability of witnesses to properly recall a person’s facial characteristics,…
The anti-anxiety effects of ketamine are associated with specific brainwave changes, according to research published…
Many people report persisting positive effects after receiving ibogaine-assisted detoxification for opioid addiction, but many…
New research provides evidence that a person’s religious beliefs can shape their experiences with psychedelic…
A new study sought to identify some of the potential psychological mechanisms that lead to smoking cessation in people who received psilocybin, the active compound in so-called magic mushrooms.
Synthetic cannabinoids can increase depression- and anxiety-like behaviors in a rodent model of trauma, according…
New research provides evidence that regular cannabis use is associated with impairments in episodic foresight, meaning the capacity to envision the future. The findings, which appear in the Journal of Psychopharmacology, suggest that cannabis can impair the ability to mentally travel into one’s personal future.
Cocaine enhances prospective memory performance, while cannabis tends to impair prospective memory, according to new…
New research provides evidence that cannabis users have a “noisier” brain compared to non-users. The…
New research indicates that previous studies examining the brain alterations caused by ecstasy have focused…
A new study has found evidence that men — but not women — who have…
A new study published in the Journal of Psychopharmacology examined why some people consume the…
A new study published in Biological Psychiatry indicates that THC, the main psychoactive constituent of…
Preliminary research suggests that psilocybin-based treatment can improve emotional processing in depressed patients. The new…